Recent discussions on X about IonQ, Inc. (IONQ) have been buzzing with excitement over the company’s latest acquisition of Oxford Ionics for $1.075 billion, a move seen as a significant step to bolster its position in the quantum computing industry. Many users on the platform have highlighted the potential for this deal to accelerate IonQ’s development of advanced quantum systems, with some pointing to ambitious projections like a 256-qubit computer by 2026. The conversation reflects a sense of anticipation about how this strategic expansion could position the company against competitors in a rapidly evolving tech landscape.
Additionally, posts on X have focused on IonQ’s recent technological breakthroughs, such as quantum-accelerated drug simulations in collaboration with major players like AstraZeneca, NVIDIA, and AWS, which reportedly achieved a 20x speedup in time-to-solution. There’s a palpable enthusiasm among discussants for the real-world applications of IonQ’s innovations, especially in fields like pharmaceuticals and optimization problems. While some express optimism about the stock’s future trajectory, others remain cautious, noting the speculative nature of quantum computing investments.
Note: This discussion summary was generated from an AI condensation of post data.
IonQ, Inc. Insider Trading Activity
IonQ, Inc. insiders have traded $IONQ stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $IONQ stock by insiders over the last 6 months:
- PETER HUME CHAPMAN (Executive Chair) has made 0 purchases and 3 sales selling 2,025,175 shares for an estimated $38,060,375.
- WILLIAM F SCANNELL purchased 93,066 shares for an estimated $2,029,508
- RIMA ALAMEDDINE (Chief Revenue Officer) has made 0 purchases and 3 sales selling 42,791 shares for an estimated $1,036,473.
- THOMAS G. KRAMER (Chief Financial Officer) has made 0 purchases and 2 sales selling 21,492 shares for an estimated $508,119.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IonQ, Inc. Hedge Fund Activity
We have seen 253 institutional investors add shares of IonQ, Inc. stock to their portfolio, and 191 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 7,835,475 shares (+7517.5%) to their portfolio in Q1 2025, for an estimated $172,928,933
- RENAISSANCE TECHNOLOGIES LLC added 2,815,800 shares (+inf%) to their portfolio in Q1 2025, for an estimated $62,144,706
- JPMORGAN CHASE & CO removed 2,103,870 shares (-85.2%) from their portfolio in Q1 2025, for an estimated $46,432,410
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 2,053,917 shares (+1211.5%) to their portfolio in Q1 2025, for an estimated $45,329,948
- AMAZON COM INC removed 1,927,061 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $80,493,337
- CITADEL ADVISORS LLC added 1,678,713 shares (+31920.8%) to their portfolio in Q1 2025, for an estimated $37,049,195
- SOFTBANK GROUP CORP. removed 1,593,315 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $66,552,767
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
